Netherlands· NL-1e6f66f887b1
Buprenorfine G.L. Pharma 0,2 mg tabletten voor sublinguaal gebruik
A buprenorphine product containing buprenorfinehydrochloride, registered in Netherlands by G.L. Pharma GmbH. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Buprenorphine is registered in 13 of 19 countries.
Countries holding a registration under ATC N02AE01 (buprenorphine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Buprenorphine · ATC N02AE01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of buprenorphine costs, country by country.
Normalised to the WHO defined daily dose (1.2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Buprenorphine · price per daily dose (1.2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.77
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BUPRENORFINEHYDROCHLORIDE
- Manufacturer
- G.L. Pharma GmbH
- Country
- Netherlands (NL)
- ATC code
- N02AE01
- ATC class
- Buprenorphine
- Defined daily dose
- 1.2 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id132208
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
378 interactions on record for buprenorphine.
Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Buprenorphine · interactions on record
378 records
- 59 severe
- 253 moderate
- 2 minor
- 52 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- DronabinolA04AD10severe
12 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Buprenorphine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBuprenorphine 200microgram sublingual tablets sugar freeA A H Pharmaceuticals Ltd
- SpainBUPREX 0,2 mg COMPRIMIDOS SUBLINGUALESEumedica Pharmaceuticals Gmbh
- FranceTEMGESIC 0,2 mg, comprimé sublingualEUMEDICA PHARMACEUTICALS (ALLEMAGNE)
- BelgiumTemgesic Sublingualis 0.2 mgEumedica Pharmaceuticals
- IrelandTemgesic 200 microgram Sublingual TabletsEumedica Pharmaceuticals GmbH
- PolandBunondolZakłady Farmaceutyczne POLPHARMA S.A.
- CzechiaADDNOKI-GEN, LDA, Caparica
- United StatesBELBUCABioDelivery Sciences International Inc
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Astec, Bupensan
- Belgium · Temgesic, Transtec
- Bulgaria · Бупренорфин G.L., Бупренорфин Актавис
- Cyprus · Buvera
- Czechia · Addnok, Buprenorfin Stada
- Germany · Acimaphin, Acinorphin
- Denmark · Buprefarm, Bupremyl
- Estonia · Buprenorphine G.L. Pharma
- Spain · Buprenorfina Andrómaco, Buprenorfina Sandoz
- Finland · Buprefarm, Bupremyl
- France · Bupensan, Buprenorphine Arrow
- United Kingdom (Northern Ireland) · Addnok, Bunov
- Greece · Buprenal, Buvera
- Croatia · Buprenorfin Alkaloid, Buprenorfin Sandoz
- Ireland · Buprenorphine Activase Pharmaceuticals, Buprenorphine Morningside Healthcare
- Iceland · Buprenorphine Alvogen, Buprenorphine Neuraxpharm
- Italy · Buprenorfina Molteni, Buprenorfina Sandoz
- Liechtenstein · Buprenorphine Neuraxpharm, Buvidal
- Luxembourg · Temgesic, Temgesic Sublingualis
- Latvia · Buprenorphine G.L. Pharma
- Malta · Buprenorphine Aspire Pharma (Malta), Natzon
- Norway · Bugnanto, Buprefarm
- Poland · Bunondol, Bunorfin
- Portugal · Buprenorfina, Buprenorfina Aurovitas
- Sweden · Buprefarm, Buprenorfin Actavis
- Slovenia · Addnok, Buprenorfin Alkaloid-Int
- Slovakia · Bupretec, Noprex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0acd6bc0-4afe-44b2-8b2e-63fa582ec1db GET /v1/drugs/0acd6bc0-4afe-44b2-8b2e-63fa582ec1db?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Sublinguaal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132208_smpc.pdf",
"strength": null,
"atc_label": "Buprenorphine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132208",
"excipients": [
"CITROENZUUR 1-WATER (E 330)",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"MANNITOL (D-) (E 421)",
"MAÏSZETMEEL",
"POVIDON K 30 (E 1201)",
"TRINATRIUMCITRAAT 2-WATER (E 331)"
],
"substances": [
"BUPRENORFINEHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132208.pdf",
"authorised_at": "2025/04/14",
"procedure_number": "SE/H/2385/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "132208",
"additional_monitoring": "N"
}See everything about buprenorphine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.